Genomics Researchers Have a Bone to Pick with Multiple Myeloma

Signal Genetics, a predictive genetic testing company focused on oncology, recently announced that it would work with pharmaceutical company Array BioPharma to advance both companies’ goals of finding biomarkers for myeloma patients.

Read more »

FDA to Review Alternative Dosing Method for Bone Marrow Drug

Most people have never heard of myelodysplastic syndrome (MDS), but approximately 10,000 to 15,000 people in the U.S. are diagnosed with it every year.

Read more »